The UK Liver Alliance is calling for liver disease to be a health priority

February 20, 2023

The UK Liver Alliance has written to the Secretary of State for Health, Steve Barclay, calling for liver disease to be appropriately recognised in policy initiatives, plans and strategies. The UK Liver Alliance is a coalition of more than 30 organisations, who are committed to improving liver health.

Following Steve Barclay’s recent Written Statement to the House, announcing the new Major Conditions Strategy, the UK Liver Alliance raised concerns around the omission of liver disease in the statement and more widely in the Department’s policy approach.

Historically liver disease has not been appropriately included in initiatives around noncommunicable diseases and is often omitted from Department of Health policy to address public health challenges.

Up to 1 in 5 people are affected by non-alcohol related fatty liver disease (NAFLD) in the UK. The Office for Health Improvements and Disparities reports that liver disease and liver cancer caused 2.5% of deaths in England in 2020. Almost half of these deaths occur in people of working age (ages 15 to 64). Liver disease has increased by 400% since the 1970s, driven by a range of factors including overweight and obesity.

Pamela Healy OBE, Chair of the UK Liver Alliance said

“Liver disease needs to be pushed up the Department for Health’s policy priority list. For too long it has been stigmatised and omitted from plans and initiatives.

This sends a terrible message to the NHS, Integrated Care Boards and GPs, around the importance of liver disease. We urgently need greater GP awareness around liver disease and better early diagnosis, treatment and care for patients.

The UK Liver Alliance will continue to promote the prioritisation of liver disease with the Secretary of State for Health, until we have the policies in place to properly manage liver disease and to start to improve care and outcomes for liver disease patients.”

The UK Liver Alliance have asked Department of Health officials to look at how the Department can meaningfully include liver disease in its policy work and specifically how it can be addressed in the Major Conditions Strategy.

Click here to read the full letter.

More news

NICE recommends maralixibat for treatment of cholestatic pruritus in Alagille Syndrome

NICE recommends maralixibat for treatment of cholestatic pruritus in Alagille Syndrome

Liver UK is delighted to hear Friday’s announcement from the National Institute for Health and Care Excellence (NICE) that they recommend maralixibat for use within the NHS for treating cholestatic pruritus (severe itch) due to ...
Liver UK visit the Senedd

Liver UK visit the Senedd

We brought our Love Your Liver Roadshow to Senedd Cymru on Tuesday 6th October, to highlight the urgent need for earlier detection and improved care in Wales. By attending with our Love Your Liver Unit, we were able to demonstrate our ...
Millions living with fatty liver disease without knowing it, UK study suggests

Millions living with fatty liver disease without knowing it, UK study suggests

New research released today at the UK’s leading liver conference shows that millions of people in the UK are living with fatty liver disease without a diagnosis. Researchers presenting new data at the British Association for the Study ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.